astra zeneca – werewolf

FILE - In this undated file photo issued by the University of Oxford on Monday, Nov. 23, 2020, a researcher in a laboratory at the Jenner Institute in Oxford, England, works on the coronavirus vaccine developed by AstraZeneca and Oxford University. With major COVID-19 vaccines showing high levels of protection, British officials are cautiously — and they stress cautiously — optimistic that life may start returning to normal by early April. Even before regulators have approved a single vaccine, the U.K. and countries across Europe are moving quickly to organize the distribution and delivery systems needed to inoculate millions of citizens. (University of Oxford/John Cairns via AP, File)

Gordon Campbell on whether we should be betting quite so heavily on Astra Zeneca’s Covid vaccine

November 27, 2020 0

According to this week’s Speech from the Throne, maintaining public safety during the pandemic will remain the government’s top priority. Next year will (hopefully) bring […]

Join the alternative to the mainstream media mind-set!

We are seeking your help to keep Werewolf.co.nz going. If you agree to become a Werewolf Sustaining Subscriber we are asking you to subscribe to pay $10, $15 (or more if you choose) a month to support Werewolf. This can be done either via:

Automatic or one-off payments to our bank account:

BNZ - Gordon Campbell. 02-0500-0890468-01

Or via paypal using your credit card:

Monthly Subscription

Make A One Off Donation

Instead of spending $10 a month on magazines and newspapers, why not pledge that to sustaining one of the most promising media prospects on the New Zealand media landscape today!